These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11285883)

  • 21. [Diabetes, Conn syndrome and osteoporosis. What is new in diagnosis and therapy?].
    Reincke M
    MMW Fortschr Med; 2003 Feb; 145(9):29. PubMed ID: 12769132
    [No Abstract]   [Full Text] [Related]  

  • 22. Osteoporosis guidelines.
    Yendt ER
    CMAJ; 2003 Jun; 168(13):1644; author reply 1645-6. PubMed ID: 12821611
    [No Abstract]   [Full Text] [Related]  

  • 23. Raloxifene remains an option.
    MacIver DW
    Can Fam Physician; 2002 Apr; 48():679; author reply 679-80. PubMed ID: 12046354
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
    Bjarnason NH
    Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].
    Higuchi T; Mizunuma H
    Clin Calcium; 2004 Oct; 14(10):81-4. PubMed ID: 15577136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of combination regimens for osteoporosis--prevention and treatment.
    Miller E; Kalin MF
    Int J Fertil Womens Med; 2002; 47(5):198-204. PubMed ID: 12469706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormone replacement Up-to-date. Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis].
    Hosoi T
    Clin Calcium; 2007 Sep; 17(9):1419-23. PubMed ID: 17767033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I;
    Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoporosis: handy tools for detection, helpful tips for treatment.
    Morgan SL; Kitchin B
    J Fam Pract; 2008 May; 57(5):311-20. PubMed ID: 18460296
    [No Abstract]   [Full Text] [Related]  

  • 31. [Delaying degeneration or promoting regeneration. 2 successful strategies in osteoporosis].
    MMW Fortschr Med; 2004 Mar; 146(10):46. PubMed ID: 15347088
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnosis and pharmacologic therapy of osteoporosis].
    Lakatos P
    Orv Hetil; 2003 Jul; 144(28):1373-9. PubMed ID: 12914121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapeutic management of osteoprosis and osteopenia.
    Alexander IM
    Nurse Pract; 2009 Jun; 34(6):30-40; quiz 41. PubMed ID: 19474629
    [No Abstract]   [Full Text] [Related]  

  • 34. Rheumatology: 15. Osteoporosis.
    Wade JP
    CMAJ; 2001 Jul; 165(1):45-50. PubMed ID: 11468955
    [No Abstract]   [Full Text] [Related]  

  • 35. [Modern treatment of primary osteoporosis].
    Bottermann P
    Internist (Berl); 1994 Dec; 35(12):1105-16. PubMed ID: 7883514
    [No Abstract]   [Full Text] [Related]  

  • 36. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
    Lee WL; Chao HT; Cheng MH; Wang PH
    Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].
    Ohta H
    Clin Calcium; 2004 Oct; 14(10):73-80. PubMed ID: 15577135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The science of selective estrogen receptor modulators: concept to clinical practice.
    Jordan VC
    Clin Cancer Res; 2006 Sep; 12(17):5010-3. PubMed ID: 16951214
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of SERMs in the management of postmenopausal osteoporosis.
    Compston J
    J Endocrinol Invest; 1999 Sep; 22(8):646-52. PubMed ID: 10532253
    [No Abstract]   [Full Text] [Related]  

  • 40. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.